0001104659-20-124781.txt : 20201113
0001104659-20-124781.hdr.sgml : 20201113
20201113105445
ACCESSION NUMBER: 0001104659-20-124781
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20200930
FILED AS OF DATE: 20201113
DATE AS OF CHANGE: 20201113
EFFECTIVENESS DATE: 20201113
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Foresite Capital Management III, LLC
CENTRAL INDEX KEY: 0001645157
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-17183
FILM NUMBER: 201309802
BUSINESS ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
BUSINESS PHONE: 415-877-4887
MAIL ADDRESS:
STREET 1: 600 MONTGOMERY STREET
STREET 2: SUITE 4500
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94111
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
false
false
0001645157
XXXXXXXX
09-30-2020
09-30-2020
false
Foresite Capital Management III, LLC
600 Montgomery Street
Suite 4500
San Francisco
CA
94111
13F HOLDINGS REPORT
028-17183
N
James B. Tananbaum
Managing Member
415-877-4887
/s/ James B. Tananbaum
San Francisco
CA
11-13-2020
0
10
134301
INFORMATION TABLE
2
infotable.xml
Acceleron Pharma Inc.
COM
00434H108
12224
108630
SH
SOLE
108630
0
0
Aclaris Therapeutics, Inc.
COM
00461U105
1760
684912
SH
SOLE
684912
0
0
Cymabay Therapeutics, Inc.
COM
23257D103
11887
1641804
SH
SOLE
1641804
0
0
Epizyme, Inc.
COM
29428V104
11909
998278
SH
SOLE
998278
0
0
FibroGen, Inc.
COM
31572Q808
7093
172500
SH
SOLE
172500
0
0
Myokardia, Inc.
COM
62857M105
54445
399360
SH
SOLE
399360
0
0
Natera, Inc.
COM
632307104
15081
208768
SH
SOLE
208768
0
0
Novavax, Inc.
COM
670002401
542
5000
SH
SOLE
5000
0
0
Oric Pharmaceuticals, Inc.
COM
06822P109
12427
496893
SH
SOLE
496893
0
0
Verona Pharma plc
SPONS ADS
925050106
6933
1111112
SH
SOLE
1111112
0
0